Purpose Infants with recurrent infection may be found to have hypogammaglobulinemia without impaired specific antibody responses. Many will be diagnosed with transient hypogammaglobulinemia of infancy. Methods This study used a parametric survival analysis of 100 infants with hypogammaglobulinemia to predict time to normalization. Results Aggregate initial immunoglobulins (IgG + IgA + IgM), as a percentage of age-adjusted normal, predicted time to resolution: median time to resolution for the infants in the lowest quartile of aggregate levels (≤81 % of age-adjusted lower limits) was greater than 5 years, with 34 % resolving in 3 years. For infants in the highest quartile (≥130 % of age-adjusted lower limits), the median was 9.9 months, with 77 % resolving in 3 years (P =0.008). Initial IgG level, as a percentage of ageadjusted normal, also predicted resolution: the median time in the lowest quartile (≤78 % of age-adjusted lower limits) was greater than 5 years, with 36 % resolving in 3 years. In the highest quartile (≥128 %), the median time was 14.5 months, with 70 % resolving in 3 years (P =0.010). Male sex was associated with more rapid resolution. The median time in males was 13 months, with 73 % resolution in 3 years. The median time in females was greater than 5 years, with 32 % resolution in 3 years. Conclusions These results suggest that if a term infant presents with hypogammaglobulinemia, protective specific antibody titers, and an absence of other known immune deficiency, initial immunoglobulin levels and sex may predict time to normalization.
Introduction
Infants with recurrent infection are often referred to allergists or immunologists because of concern about possible immune system dysfunction, and hypogammaglobulinemia, without impaired specific antibody responses, may be found. Such infants are usually considered to have transient hypogammaglobulinemia of infancy (THI), which has been defined by the International Union of Immunological Societies (IUIS) as a transient delay reaching normal levels of IgG and IgA [1] . However, it has recently been shown that infants with an isolated decrease in IgA are clinically similar to infants with decreased IgG and IgA [2] . Transient hypogammaglobulinemia of infancy has been associated with increased production of TNF-alpha, TNF-beta, and IL-10, which are thought to favor cellular immune responses rather than antibody production [3] . Alternatively, a report in 1981 associated THI with numerical and functional deficiency of helper T-cells [4] ; more recently, however, THI has been associated with a transient increase in numbers of regulatory T-cells [5] .
Complicating the assessment and prognostication about infants with hypogammaglobulinemia is the reality that a diagnosis of THI can only be established in retrospect, after immunoglobulin levels have normalized [6] . Some infants with hypogammaglobulinemia will not have resolution of their deficiency, and those with persistent hypogammaglobulinemia may be at increased risk for recurrent infection and autoimmune disease [7] . At the time of initial recognition of hypogammaglobulinemia in an infant with recurrent infections, immunologists are often confronted with clinically relevant questions regarding the likely duration of hypogammaglobulinemia. Previous studies have shown that males are more likely than females to have resolution of hypogammaglobulinemia during infancy [8] ; however, other than this observation, there has been little information that would allow an informed prediction about the probable time to resolution. The goal of this study was to define parameters present at the time of diagnosis that might predict time to resolution of hypogammaglobulinemia.
Methods

Subjects
Between 1978 and 2011, 100 infants with hypogammaglobulinemia were identified during routine clinical evaluation in the Division of Allergy, Asthma, and Clinical Immunology at Nemours/Alfred I. duPont Hospital for Children (Wilmington, DE) and Thomas Jefferson University (Philadelphia, PA). Infants were included in the study if they had: 1) a level of any immunoglobulin class that was below the 5th percentile of the age-adjusted mean, 2) were younger than 24 months at the time of diagnosis, 3) were born at greater than 36 weeks gestation, 4) had evidence of protective diphtheria and tetanus titers following immunization, and 5) had no other known primary immune deficiency. Infants were excluded from the study if they were born prematurely (i.e., less than 36 weeks gestation), if diphtheria and tetanus antibody titers post immunization were not protective, or if there was another known primary immune deficiency. The institutional review board reviewed the protocol and waived the requirement for parental informed consent.
Statistics
Infants were grouped into quartiles on the basis of the sum of initial IgG + IgA + IgM, viewed as a percentage of the lower limit of age-appropriate normal values (Fig. 1) . Therefore, as shown in Fig. 1 , calculation of percent of normal is done as if the lower limit or normal IgG + IgA + IgM in an 11-month-old infant is 438 mg/dl and a hypothetical study infant's aggregate is 300 mg/dl, that infant's immunoglobulins are 68.5 % of normal, and assignment to quartiles is on this basis. The higher quartiles may exceed 100 % of normal as some immunoglobulin isotypes fall within the normal range, and only one isotype (e.g., IgG) may be deficient. The same assessment is applied to IgG levels as predictors of normalization time, only restricted to that immunoglobulin class. In a separate analysis, infants were grouped into quartiles on the basis of the initial IgG, viewed as a percentage of the lower limit of age-appropriate normal values (Fig. 2 ). And in a final analysis, infants were grouped using sex since earlier evaluations described sex difference. Published normal values were utilized [9] , and the lower limit of normal was derived by taking the mean of the pooled normal values less 2 standard deviations. Quartiles were established by dividing the accumulated patient data, expressed as percent of lower limit of normal, into four equal parts. The same normal values were used throughout the study. Quartiles were compared with one another regarding time to resolution using interval censored data and parametric survival analysis (SAS version 9.1.3). Interval censored data were used because an actual date of normalization is not known; only an interval during which a patient's immunoglobulin levels normalized is known. Prior studies checked the reasonableness of this model by KaplanMeier curves, using interval midpoints as time to normalization, and found very similar results compared with those of model-based graphs [8] . Quartiles were compared with one another regarding age at diagnosis and percentage male using Kruskal-Wallis and chi-squared methods, respectively.
Results
In this total cohort, the median age at diagnosis was 11.3 months, and 71 % of the subjects were male. Initial immunoglobulin determination was obtained most frequently because of recurrent otitis media and upper respiratory tract infection (67 %), recurrent lower respiratory tract infection (24 %), or failure to thrive (14 %) ( Table I) . There was no statistically significant difference in age at diagnosis or percentage male when the study population was divided into quartiles on the basis of initial aggregate immunoglobulin subtypes as a percentage of normal (Table II) . There was a statistically significant association of quartile of aggregate immunoglobulin isotypes as percentile of age-adjusted lower limit of normal and time to resolution (P =0.008). The median time to resolution for the infants in the lowest quartile of immunoglobulins (≤81 % of ageadjusted lower limits of normal) was greater than 5 years, with only 34 % resolving in 3 years. For infants in the highest quartile (≥130 % of age-adjusted lower limits of normal), the median time to resolution was 9.9 months, with 77 % resolving in 3 years. Results for the other two quartiles are intermediate but not significantly different in those for the highest quartile (Fig. 3) .
There was also no statistically significant difference in age at diagnosis and percentage male when the study population was divided into quartiles on the basis of initial IgG level alone when expressed as percentage of normal (Table III) . There was a statistically significant association of quartile of isolated IgG percentile age-adjusted lower limit of normal and time to resolution (P =0.010). The median time to resolution in the lowest quartile (≤78 % of age-adjusted lower limits of normal) was greater than 5 years, with only 36 % resolving in 3 years. For infants in the highest quartile (≥128 %), the median time to resolution was 14.5 months, with 70 % resolving in 3 years (Fig. 4) .
In agreement with previously reported findings [8] , male infants resolved more quickly than females (P =0.001). The median time to resolution in males was 13 months, with 73 % resolving in 3 years. The median time to resolution in females was greater than 5 years, with 32 % resolving in 3 years (Fig. 5) .
Discussion
Many infants with hypogammaglobulinemia have resolution of their decreased immunoglobulin levels enabling a diagnosis of THI; however, a subset of these children have significantly delayed normalization of immunoglobulin levels or receive alternative diagnoses. In our series, 17 % of infants whom we observed past 3 years of age remained hypogammaglobulinemic, and 2 % were reclassified as having selective IgA deficiency [2, 8] . Of note is that none were subsequently found to have common variable immunodeficiency (CVID). It may be important to discriminate between infants who are likely to have early resolution of hypogammaglobulinemia and infants who are likely to have persistence because there is evidence that infants with prolonged unresolved hypogammaglobulinemia are more likely to have recurrent infection and autoimmune problems [7] . Ability to discriminate between infants who recover early and those who recover much later may incline physicians toward treatment of the latter group with intravenous immunoglobulin (IVIG) replacement, antimicrobial prophylaxis, or both [7] . This study confirms an easily understood hypothesis: infants with mild or moderate decreases in initial aggregate immunoglobulin levels or IgG levels alone are more likely to outgrow their immunologic deficiency and to do so sooner than with infants with greater decreases in immunoglobulin levels. Not surprisingly, we find that infants with higher initial aggregate immunoglobulin levels do have a greater probability of prompt resolution. This finding is in contrast to the report of Karaca et al. who found that the subjects with lower initial IgG levels recovered normal levels earlier [10] . A major contribution of this study is that immunoglobulin levels have been delineated, using the concept of percentage normal for age, allowing a clinician to estimate the probability of resolution for hypogammaglobulinemia in infants without evidence of another primary immune deficiency by a particular age. At the time of initial evaluation, immunologists may use aggregate immunoglobulin levels or initial IgG levels to predict probability of resolution, although the aggregate immunoglobulin level does so with greater power. Although other markers such as cytokine level measurements [3] or regulatory T-cell number measurements [5] have been associated with resolution of hypogammaglobulinemia, these markers are not readily available outside a research setting and are, therefore, of little use to most clinicians. Aggregate immunoglobulin as a percentage of minimal normal and IgG as a percentage of minimal normal can be easily calculated by a practicing clinician and may be of significant practical utility. Unlike Karaca et al. [10] , who found no significant difference in the recovery time of male and female subjects, we found that male sex was associated with more prompt resolution of hypogammaglobulinemia. It is unclear why hypogammaglobulinemic male infants, though more prevalent, tend to resolve their initial hypogammaglobulinemia more rapidly than females, but the finding has been noted in two prior studies involving 49 and 87 infants, respectively [2, 8] . It is notable that the male sex was overrepresented in our study population, with males composing 71 % of our patients. Other reports of infants with hypogammaglobulinemia have also had similarly disproportionate numbers of male infants [10] [11] [12] . It is possible that studies defining "normal" immunoglobulin levels by age may not accurately reflect naturally occurring differences in immunoglobulin levels due to sex or racial differences, thereby predisposing male infants to overdiagnosis of hypogammaglobulinemia. Further studies may be needed to define the normal immunoglobulin maturation patterns between males and females.
Conclusions
These results suggest that if a term infant presents with hypogammaglobulinemia, protective specific antibody titers, and an absence of other known immune deficiency, an immunologist may use the sum of initial IgG + IgA + IgM levels to predict time to normalization. Furthermore, the initial IgG level also allows estimation of time to resolution. And, male sex was associated with more prompt resolution of symptoms. Further study is warranted to elucidate possible long-term sequelae of hypogammaglobulinemia during infancy and the pathophysiologic mechanisms that underlie hypogammaglobulinemia during infancy.
